Cero Therapeutics Holdings CERO
OTC CERO
$0.01 +0.01 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings (CERO) Debt Ratio (2022 - 2026)

Updated

Cero Therapeutics Holdings' Debt Ratio came in at 0.39 for Q2 2026.

Analysis

Cero Therapeutics Holdings (CERO) Debt Ratio (2022 - 2026) Analysis & Trends

For FY2023, Cero Therapeutics Holdings' Debt Ratio was 0.12, up 662.5% from FY2022.

  • Going back by year, Debt Ratio was 0.02 in FY2022.
  • The Q2 2026 figure represents the highest quarterly Debt Ratio in data going back to Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 0.39
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 0.23
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 0.52
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 0.42
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 0.08
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 0.28
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 0.60
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 0.53
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 0.31
10 Cero Therapeutics Holdings 638,128.24 -4.84 Mn - 0.39
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.39
Sep 30, 2024 0.02
Jun 30, 2024 0.03
Mar 31, 2024 0.04
Dec 31, 2023 0.12
Sep 30, 2023 0.16
Jun 30, 2023 0.08
Mar 31, 2023 0.05
Dec 31, 2022 0.02
API Access

Cero Therapeutics Holdings Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CERO&period=max&api_key=YOUR_API_KEY